Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The choanoflagellate pore-forming lectin SaroL-1 punches holes in cancer cells by targeting the tumor-related glycosphingolipid Gb3. | Commun Biol | 2022 | 36097056 | PubTator, text mining | PubMed |
| Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2+ breast cancer by ceramide-loaded nanoparticles. | Proc Natl Acad Sci U S A | 2022 | 36095190 | PubTator, text mining | PubMed |
| Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner. | J Med Chem | 2022 | 36074125 | PubTator, text mining | PubMed |
| Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. | iScience | 2022 | 36065182 | PubTator, text mining | PubMed |
| Phenotypic expression of swallowing function in Niemann-Pick disease type C1. | Orphanet J Rare Dis | 2022 | 36064725 | PubTator, text mining | PubMed |
| Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions. | Clin Pharmacol Ther | 2022 | 36056771 | PubTator, text mining | PubMed |
| Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry. | Am J Hematol | 2022 | 36054609 | PubTator, text mining | PubMed |
| Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation. | Front Immunol | 2022 | 36052066 | PubTator, text mining | PubMed |
| Targeting the Sphingolipid Rheostat in Gliomas. | Int J Mol Sci | 2022 | 36012521 | PubTator, text mining | PubMed |
| Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease. | Int J Mol Sci | 2022 | 36012454 | PubTator, text mining | PubMed |
| Dysregulated sphingolipid metabolism and autophagy in granulosa cells of women with endometriosis. | Front Endocrinol (Lausanne) | 2022 | 35992117 | PubTator, text mining | PubMed |
| Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy. | Elife | 2022 | 35972072 | PubTator, text mining | PubMed |
| What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs. | Neurology | 2022 | 35970592 | PubTator, text mining | PubMed |
| The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance. | Front Oncol | 2022 | 35965565 | PubTator, text mining | PubMed |
| Delivery of Nucleotide Sugars to the Mammalian Golgi: A Very Well (un)Explained Story. | Int J Mol Sci | 2022 | 35955785 | PubTator, text mining | PubMed |
| Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. | World J Clin Cases | 2022 | 35949853 | PubTator, text mining | PubMed |
| Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer. | Front Immunol | 2022 | 35935965 | PubTator, text mining | PubMed |
| Type 2 diabetes disrupts circadian orchestration of lipid metabolism and membrane fluidity in human pancreatic islets. | PLoS Biol | 2022 | 35921354 | PubTator, text mining | PubMed |
| Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with disease. | PLoS One | 2022 | 35921286 | PubTator, text mining | PubMed |
| 1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease. | J Am Chem Soc | 2022 | 35917590 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=18